Anidulafungin

Active ingredient description

Anidulafungin is a semi-synthetic echinocandin, a lipopeptide synthesised from a fermentation product of Aspergillus nidulans. Anidulafungin selectively inhibits 1,3-β-D glucan synthase, an enzyme present in fungal, but not mammalian cells.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
J02AX06
Anidulafungin
J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AX Other antimycotics for systemic use
Discover more medicines within J02AX06

Medicines

Anidulafungin is the active ingredient of these drugs:

Drug
Countries
CARIXAN

South Africa

ECALTA

Austria Brazil Cyprus Finland France

ERAXIS

Canada Hong Kong Singapore South Africa United States

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
ECALTA Powder for concentrate for solution for infusion
Summary of Product Characteristics (SPC)
ERAXIS Solution for injection
Structured Product Labeling (SPL/PLR)
US

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

9HLM53094I - ANIDULAFUNGIN

CAS registry number

166663-25-8 - anidulafungin

SNOMED-CT

422157006 - Anidulafungin (substance)

Next: Usage